Clinical trial
A Phase I/II, Double-blind, Randomized, Active-controlled, Age De-escalation Trial to Assess Safety and Immunogenicity of a Measles Rubella Vaccine (MRV) Microneedle Patch (MRV-MNP) in Adults, MRV-primed Toddlers, and MRV-naïve Infants
NCT04394689 is registered in ClinicalTrials.gov with Micron Biomedical, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II, Double-blind, Randomized, Active-controlled, Age De-escalation Trial to Assess Safety and Immunogenicity of a Measles Rubella Vaccine (MRV) Microneedle Patch (MRV-MNP) in Adults, MRV-primed Toddlers, and MRV-naïve Infants
- Lead sponsor
- Micron Biomedical, Inc
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 19, 2021
- Completion date
- December 31, 2022
- Enrollment
- 281 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.